Picard Medical is trading at $4.80, up 5.49%, primarily on strength across the healthcare sector. - Shares are outperforming a mostly weaker broader market during the September 24, 2026 session. - Healthcare stocks are gaining 1.27%, supported by renewed biotechnology optimism, acquisition activity and favorable regulatory sentiment. - No fresh company-specific announcement was identified for September 24; the latest notable company-related coverage concerns an earlier shareholder litigation investigation.